Telix Pharmaceuticals Limited Stock Price History

TLX Stock   18.24  0.45  2.53%   
If you're considering investing in Telix Stock, it is important to understand the factors that can impact its price. As of today, the current price of Telix Pharmaceuticals stands at 18.24, as last reported on the 25th of March, with the highest price reaching 18.55 and the lowest price hitting 18.04 during the day. Telix Pharmaceuticals appears to be not too volatile, given 3 months investment horizon. Telix Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0685, which indicates the firm had a 0.0685 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Telix Pharmaceuticals Limited, which you can use to evaluate the volatility of the company. Please review Telix Pharmaceuticals' Semi Deviation of 2.73, risk adjusted performance of 0.0815, and Coefficient Of Variation of 1215.02 to confirm if our risk estimates are consistent with your expectations.
  
At this time, Telix Pharmaceuticals' Total Stockholder Equity is fairly stable compared to the past year. Common Stock Shares Outstanding is likely to rise to about 351.5 M in 2025, whereas Capital Stock is likely to drop 0.00 in 2025. . Price To Sales Ratio is likely to drop to 8.16 in 2025. Price Earnings Ratio is likely to drop to -149.47 in 2025. Telix Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0685

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsTLX
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 3.32
  actual daily
29
71% of assets are more volatile

Expected Return

 0.23
  actual daily
4
96% of assets have higher returns

Risk-Adjusted Return

 0.07
  actual daily
5
95% of assets perform better
Based on monthly moving average Telix Pharmaceuticals is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Telix Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book
20.7055
Enterprise Value Ebitda
113.1305
Price Sales
8.0923
Shares Float
282.3 M
Wall Street Target Price
20.1866

Telix Pharmaceuticals Stock Price History Chart

There are several ways to analyze Telix Stock price data. The simplest method is using a basic Telix candlestick price chart, which shows Telix Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceFebruary 24, 202520.93
Lowest PriceJanuary 13, 202514.56

Telix Pharmaceuticals March 25, 2025 Stock Price Synopsis

Various analyses of Telix Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Telix Stock. It can be used to describe the percentage change in the price of Telix Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Telix Stock.
Telix Pharmaceuticals Accumulation Distribution 432.52 
Telix Pharmaceuticals Price Action Indicator 0.17 
Telix Pharmaceuticals Price Rate Of Daily Change 1.03 
Telix Pharmaceuticals Price Daily Balance Of Power 0.88 

Telix Pharmaceuticals March 25, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Telix Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Telix Pharmaceuticals intraday prices and daily technical indicators to check the level of noise trading in Telix Stock and then apply it to test your longer-term investment strategies against Telix.

Telix Stock Price History Data

The price series of Telix Pharmaceuticals for the period between Wed, Dec 25, 2024 and Tue, Mar 25, 2025 has a statistical range of 6.37 with a coefficient of variation of 7.7. The price distribution for the period has arithmetic mean of 17.19. The median price for the last 90 days is 17.35. The company completed stock split (1:1000) on 29th of October 2013.
OpenHighLowCloseVolume
03/24/2025 18.19  18.55  18.04  18.24  15,732 
03/21/2025 18.81  18.86  17.51  17.79  24,184 
03/20/2025 18.66  18.66  17.50  17.53  15,300 
03/19/2025 17.71  17.74  17.50  17.60  13,647 
03/18/2025 17.26  17.35  17.05  17.30  20,983 
03/17/2025 17.39  17.70  17.16  17.60  15,293 
03/14/2025 17.21  17.38  17.10  17.30  15,714 
03/13/2025 17.79  17.79  16.95  16.99  18,233 
03/12/2025 17.24  17.28  16.93  17.16  21,559 
03/11/2025 17.41  17.62  16.56  16.75  135,061 
03/10/2025 18.00  18.16  17.55  17.85  104,668 
03/07/2025 18.05  19.88  18.01  18.40  53,557 
03/06/2025 17.81  18.51  17.77  18.20  24,372 
03/05/2025 17.51  17.98  17.40  17.70  23,304 
03/04/2025 17.70  18.50  16.75  17.51  49,800 
03/03/2025 18.01  18.68  17.92  18.05  51,358 
02/28/2025 17.80  18.69  17.60  17.98  41,152 
02/27/2025 19.30  19.30  18.60  18.90  48,908 
02/26/2025 19.40  20.40  19.13  19.20  86,300 
02/25/2025 20.00  20.57  19.44  19.50  87,719 
02/24/2025 19.50  30.36  19.50  20.93  382,726 
02/21/2025 19.13  20.00  19.01  19.50  39,652 
02/20/2025 17.02  17.75  17.02  17.41  19,000 
02/19/2025 17.41  17.41  16.92  17.19  11,900 
02/18/2025 17.53  18.77  17.35  17.35  4,600 
02/14/2025 17.00  17.86  17.00  17.19  24,036 
02/13/2025 17.55  18.38  17.16  17.29  18,171 
02/12/2025 17.45  17.72  17.23  17.60  17,369 
02/11/2025 17.99  17.99  17.45  17.64  22,162 
02/10/2025 18.70  18.82  18.09  18.09  17,400 
02/07/2025 18.44  19.09  18.02  18.05  8,000 
02/06/2025 18.50  19.02  18.01  18.29  13,710 
02/05/2025 18.63  19.02  18.40  18.43  11,500 
02/04/2025 18.45  19.10  18.45  18.90  16,800 
02/03/2025 18.25  18.63  17.99  18.36  50,100 
01/31/2025 18.90  19.19  18.30  18.60  29,100 
01/30/2025 18.59  18.75  18.20  18.20  11,400 
01/29/2025 18.80  18.89  18.01  18.59  8,600 
01/28/2025 18.40  18.96  18.11  18.11  19,400 
01/27/2025 18.90  19.20  17.90  18.01  24,700 
01/24/2025 17.88  19.12  17.64  18.24  8,500 
01/23/2025 17.04  17.99  17.00  17.13  28,400 
01/22/2025 17.12  17.95  16.81  17.04  16,800 
01/21/2025 18.00  18.00  16.77  16.86  17,300 
01/17/2025 16.40  18.04  16.40  16.78  31,600 
01/16/2025 16.15  16.25  15.70  16.00  18,500 
01/15/2025 15.72  16.25  15.54  15.61  1,900 
01/14/2025 15.29  15.66  15.24  15.52  4,700 
01/13/2025 14.25  14.97  14.01  14.56  18,900 
01/10/2025 15.25  15.34  14.63  14.63  11,200 
01/08/2025 15.45  15.57  15.34  15.35  8,400 
01/07/2025 15.81  15.99  15.45  15.45  3,800 
01/06/2025 15.68  16.05  15.41  15.61  7,500 
01/03/2025 14.89  15.50  14.89  14.93  3,700 
01/02/2025 15.53  15.53  14.44  15.00  5,300 
12/31/2024 15.80  16.05  15.40  15.40  2,100 
12/30/2024 16.38  16.38  15.70  16.10  14,100 
12/27/2024 16.40  16.40  15.37  15.60  3,800 
12/26/2024 16.00  16.46  15.95  16.46  1,300 
12/24/2024 14.57  16.31  14.57  15.88  1,100 
12/23/2024 15.80  17.29  15.40  15.40  7,500 

About Telix Pharmaceuticals Stock history

Telix Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Telix is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Telix Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Telix Pharmaceuticals stock prices may prove useful in developing a viable investing in Telix Pharmaceuticals
Last ReportedProjected for Next Year
Common Stock Shares Outstanding334.7 M351.5 M

Telix Pharmaceuticals Quarterly Net Working Capital

587.65 Million

Telix Pharmaceuticals Stock Technical Analysis

Telix Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Telix Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Telix Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Equity Search Now

   

Equity Search

Search for actively traded equities including funds and ETFs from over 30 global markets
All  Next Launch Module

Telix Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Telix Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Telix Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Telix to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Telix Stock Analysis

When running Telix Pharmaceuticals' price analysis, check to measure Telix Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Telix Pharmaceuticals is operating at the current time. Most of Telix Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Telix Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Telix Pharmaceuticals' price. Additionally, you may evaluate how the addition of Telix Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.